3. Characteristics of the included interventions: format.
Study (PEM) | Format* | Appearance§ | Length¥ |
Austin 2003 (HERS trial report) | 1 | 1 | 1 |
Austin 2004‐A (WHI trial report) | 1 | 1 | 1 |
Austin 2004‐B (ALLHAT trial report) | 1 | 1 | 1 |
Austin 2005 | 1 | 1 | 1 |
Avorn 1983 | 2 | 3 | 3 |
Azocar 2003 | 2 | 3 | 2 |
Barbaglia 2009 (WHI trial report) | 1 | 1 | 1 |
Bearcroft 1994 | 3 | 3 | 3 |
Beaulieu 2004 | 2 | 3 | 2 |
Bjornson 1990 | 1 | 1 | 1 |
Black 2002 (EHC‐OM bulletin) | 4 | 1 | 1 |
Buyle 2010 | 4 | 3 | 3 |
Coopersmith 2002 | 6 | 3 | 1 |
Denig 1990 | 4 | 1 | 3 |
Dormuth 2004 | 4 | 2 | 1 |
Fijn 2000 | 3 | 3 | 3 |
Fonarow 2009 (MIRACL trial report) | 1 | 1 | 1 |
Fonarow 2009 (PROVE‐IT TIMI 22 trial report) | 1 | 1 | 1 |
Fonarow 2009 (ACC‐AHA‐STEMI guidelines) | 3 | 1 | 1 |
Fonarow 2009 (AHA‐AHA‐NS guidelines) | 3 | 1 | 1 |
Fukuda 2009 | 3 | 3 | 3 |
Guay 2007 (WHI publication) | 1 | 1 | 1 |
Haas 2004 (HERS publication) | 1 | 1 | 1 |
Haas 2004 (WHI publication) | 1 | 1 | 1 |
Hersh 2004 (WHI; HERS; HERSIII publications) | 1 | 1 | 1 |
Jackevicius 2001 | 1 | 1 | 1 |
Jameson 2010 | 3 | 3 | 3 |
Jousimaa 2002 | 3 | 3 | 1 |
Juurlink 2004 | 1 | 1 | 1 |
Kabir 2007 (LIFE publication) | 1 | 1 | 1 |
Kabir 2007 (ALLHAT publication) | 1 | 1 | 1 |
Kabir 2007 (VALUE trial report) | 1 | 1 | 1 |
Kajita 2012 | 3 | 3 | 3 |
Kottke 1989 | 5 | 3 | 1 |
Lam 2009 | 1 | 1 | 1 |
Majumdar 2003 (HOPE trial report) | 1 | 1 | 1 |
Majumdar 2003 (RALES trial report) | 1 | 1 | 1 |
Majumdar 2004 (WHI trial report) | 1 | 1 | 1 |
Mason 1998 | 4 | 1 | 1 |
Mason 2001 (EHC‐OM bulletin) | 4 | 1 | 1 |
Matowe 2002 | 3 | 3 | 3 |
Meyer 2007 | 3 | 3 | 3 |
Oakeshott 1994 | 3 | 3 | 2 |
Perria 2007 | 3 | 3 | 3 |
Roberts 2007 | 3 | 1 | 1 |
Santerre 1996 | 3 | 3 | 3 |
Shah 2008 | 1 | 1 | 1 |
Stafford 2004 (ALLHAT trial report) | 1 | 1 | 1 |
Tsuji 2009 | 6 | 3 | 3 |
Wang 2005 (ADA guidelines; ATP III trial report) | 1 | 1 | 1 |
Watson 2001 | 3 | 3 | 3 |
Weiss 2011 | 3 | 2 | 1 |
* Format: 1 = publication of RCT in peer‐reviewed journal; 2 = quick reference of clinical guidelines; 3 = full clinical guidelines; 4 = newsletter/bulletin; 5 = manual of peer‐reviewed clinical article reprints; 6 = other.
§ Appearance: 1 = black and white, with a few figures/tables; 2 = enhanced communication format (colour, picture, or figure); 3 = unclear.
¥ Length: 1 = more than two pages; 2 = two pages or less; 3 = unclear.